Cargando…
Cardiac Organoids to Model and Heal Heart Failure and Cardiomyopathies
Cardiac tissue engineering aims at creating contractile structures that can optimally reproduce the features of human cardiac tissue. These constructs are becoming valuable tools to model some of the cardiac functions, to set preclinical platforms for drug testing, or to alternatively be used as the...
Autores principales: | Seguret, Magali, Vermersch, Eva, Jouve, Charlène, Hulot, Jean-Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157277/ https://www.ncbi.nlm.nih.gov/pubmed/34069816 http://dx.doi.org/10.3390/biomedicines9050563 |
Ejemplares similares
-
Human Cardiac Organoids for Modeling Genetic Cardiomyopathy
por: Filippo Buono, Michele, et al.
Publicado: (2020) -
Differential Sarcomere and Electrophysiological Maturation of Human iPSC-Derived Cardiac Myocytes in Monolayer vs. Aggregation-Based Differentiation Protocols
por: Jeziorowska, Dorota, et al.
Publicado: (2017) -
Editorial: Heart failure with preserved ejection fraction: Basic, translational, and clinical research
por: Brette, Fabien, et al.
Publicado: (2022) -
From engineered heart tissue to cardiac organoid
por: Cho, Jaeyeaon, et al.
Publicado: (2022) -
Aetiological classification and prognosis in patients with heart failure with preserved ejection fraction
por: Fayol, Antoine, et al.
Publicado: (2021)